ß(1)-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome

Documenti analoghi

• β(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome
  di: De Leersnyder, H., et al.
  Pubblicazione: (2001)
• Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome
  di: Potocki, L., et al.
  Pubblicazione: (2000)
• Abnormal Circadian Rhythm of Melatonin in Smith-Magenis Syndrome Patients with RAI1 Point Mutations
  di: Boone, Philip M., et al.
  Pubblicazione: (2011)
• Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder
  di: Poisson, Alice, et al.
  Pubblicazione: (2019)
• Diagnostic Utility of Daytime Salivary Melatonin Levels in Smith-Magenis Syndrome
  di: Chik, Constance L., et al.
  Pubblicazione: (2010)